Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.5 (
RNase
)
17,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A recombinant plasmid harboring heterologous genes coding human
ribonuclease/angiogenin inhibitor
(
RAI
) was expressed in stably transformed Drosophila melanogaster Schneider 2 (S2) cells. Stably transformed polyclonal cell populations expressing
RAI
were isolated after 4 weeks of selection with hygromycin B. Recombinant
RAI
with a molecular weight of 50 kDa was detected in the intracellular (cell) and extracellular (medium) fractions of S2 cells. Recombinant
RAI
was purified from the extracellular fraction using a two-step purification scheme comprised of Ni-NTA and ion-exchange chromatography. Purified
RAI
migrated on SDS-PAGE as a single band in the elution fraction containing 300 mM NaCl. The
ribonuclease
inhibitor activity of purified
RAI
was measured using yeast tRNA and
RNase A
. Purified
RAI
exhibited an activity of approximately 8 U mug(-1) for the inhibition of RNA degradation by
RNase A
. Cultivation of stably transformed S2 cells using HyQ((R))SFX-insect MP medium increased cell growth by 79% and approximately doubled the production of recombinant
RAI
.
...
PMID:Functional expression of recombinant human ribonuclease/angiogenin inhibitor in stably transformed Drosophila melanogaster S2 cells. 1900 77